Evidence map›Paper›PMID 34914750›Full record

ArticlePloS one2021

A broad-spectrum cloning vector that exists as both an integrated element and a free plasmid in Chlamydia trachomatis.

Lotisha Garvin, Rebecca Vande Voorde, Mary Dickinson, Steven Carrell, Kevin Hybiske, Daniel Rockey

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Requirement of GrgA forbioRxiv : the preprint server for biology · 2023
    Article
  5. Article
  6. The Impact of Lateral Gene Transfer inFrontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lotisha GarvinDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States of America.ORCID 0000-0003-0877-8290
Rebecca Vande VoordeDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States of America.
Mary DickinsonDivision of Allergy and Infectious Diseases, Department of Medicine, Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Seattle, WA, United States of America.
Steven CarrellDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States of America.
Kevin HybiskeDivision of Allergy and Infectious Diseases, Department of Medicine, Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Seattle, WA, United States of America.
Daniel RockeyDepartment of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States of America.ORCID 0000-0003-0663-9916
Oregon State University · USUniversity of Washington · US

Funding

Functional genomics for ChlamydiaR01AI126785 · NIAID · UNIVERSITY OF WASHINGTON · PI HEFTY, P SCOTT, HYBISKE, KEVIN · 2016 to 2025
$7.1M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Genome-wide analysis of lateral gene transfer in Chlamydia trachomatisR21AI144865 · NIAID · OREGON STATE UNIVERSITY · PI ROCKEY, DANIEL D · 2020 to 2021
$428k
NIAID NIH HHS R01 AI126785NIAID NIH HHS R21 AI144865NIAID NIH HHS T32 AI007509
6 · The paper itself

Abstract

Plasmid transformation of chlamydiae has created new opportunities to investigate host-microbe interactions during chlamydial infections; however, there are still limitations. Plasmid transformation requires a replicon derived from the native Chlamydia plasmid, and these transformations are species-specific. We explored the utility of a broad host-range plasmid, pBBR1MCS-4, to transform chlamydiae, with a goal of simplifying the transformation process. The plasmid was modified to contain chromosomal DNA from C. trachomatis to facilitate homologous recombination. Sequences flanking incA were cloned into the pBBR1MCS-4 vector along with the GFP:CAT cassette from the pSW2-GFP chlamydial shuttle vector. The final plasmid construct, pBVR2, was successfully transformed into C. trachomatis strain L2-434. Chlamydial transformants were analyzed by immunofluorescence microscopy and positive clones were sequentially purified using limiting dilution. PCR and PacBio-based whole genome sequencing were used to determine if the plasmid was maintained within the chromosome or as an episome. PacBio sequencing of the cloned transformants revealed allelic exchange events between the chromosome and plasmid pBVR2 that replaced chromosomal incA with the plasmid GFP:CAT cassette. The data also showed evidence of full integration of the plasmid into the bacterial chromosome. While some plasmids were fully integrated, some were maintained as episomes and could be purified and retransformed into E. coli. Thus, the plasmid can be successfully transformed into chlamydia without a chlamydial origin of replication and can exist in multiple states within a transformed population.

Indexed as

Genetic VectorsTransformation, BacterialChlamydia InfectionsChlamydia trachomatisChromosomes, BacterialGreen Fluorescent ProteinsPlasmidsGreen Fluorescent Proteins

Identifiers

PMID34914750
PMCPMC8675754
OpenAlexW4200015580

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.